Estrogen receptor dinucleotide repeat polymorphism is associated with minimal or mild endometriosis

article OA: bronze CC0 ⤵ 18 in-corpus citations
AI-generated summary by gemini-2.5-flash-lite, 2026-06-08

A dinucleotide repeat polymorphism in the estrogen receptor gene was found to be associated with minimal or mild endometriosis in this study.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

The present study was designed to explore the association between estrogen receptor-alpha gene polymorphism and the risk of endometriosis by investigating the frequency of PvuII, XbaI, and thymine-adenine (TA) repeat polymorphisms in patients with and without endometriosis in a Korean population. Although there was no significant difference in the allele distribution and frequency of either PvuII or XbaI polymorphisms between endometriosis patients and control subjects, patients with stage I/II endometriosis showed a higher incidence of alleles with fewer (TA)n repeats (12-15 repeats) compared with controls.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Dinucleotide Repeats Endometriosis Estrogen Receptor alpha Polymorphism, Genetic Adult Alleles Asian People Asian People Dinucleotide Repeats Endometriosis Endometriosis Estrogen Receptor alpha Female Humans Korea Middle Aged Odds Ratio

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (9)

Cited by (17)

Source provenance

europepmc
last seen: 2026-09-03T06:15:13.668130+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:15:29.922408+00:00
License: CC0 · commercial use OK